Delivery Order SPE2DB20D1051-SPE2DB25FD9PE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,712.25. This non-set-aside award represents a competitive procurement for pharmaceutical products to support federal healthcare needs. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $34,830.84. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 9, 2025, with fulfillment from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a specific pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $6,429.02. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, effective through May 30, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $14,758.55, with an ultimate completion date of September 25, 2025. This non-set-aside, competitively awarded delivery order was issued on September 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract valued at $1,122.20. The award, which is effective through August 19, 2025, was issued as a non-set-aside competitive award and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,637.19. The delivery order, which represents a child contract under a larger vehicle, carries an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9PEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,091.46. This is a non-set-aside competitive award with an ultimate completion date of September 23, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents pharmaceutical procurement to support federal medical supply needs, particularly for military and veteran healthcare systems managed through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. This comprehensive prime vendor contract enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's portfolio of federal contract awards demonstrates significant capability in fulfilling diverse medical procurement requirements, including specialty medications, brand-name and generic drugs, and other healthcare commodities across multiple therapeutic domains serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/22/25 |